Growth hormone and estrogen pharmacogenetics in patients with Turner Syndrome
Evaluation of the delay in the initiation and intensity of estrogen replacement th...
Determination of risk factors for cardiovascular disease in Turner Syndrome patien...
Sexual differentiation mechanisms in chromosomal aneuploidies: a correlation with ...
Methylenetetrahydrofolate Reductase (MTHFR) polymorphisms as a risk factor for Tur...
Validation, normative date and clinical utility of and enzymeimmunoassay for serum...
Molecular diagnosis of disturbances of sexual differentiation